Agilent Technologies Inc. (NYSE: A) and Chungnam National University announced new initiatives to further research in glycomics, the study of complex sugars, in order to develop biomarkers and new therapeutic antibodies to combat diseases such as cancer.
Read about it here!
Agilent Technologies and Chungnam National University Announce Glycomics Research Initiatives
AMP 